Search

67 results
  1. Futurapolis Santé 2023: New feats of health science

    The Futurapolis Santé health event returns to Montpellier on October 13-14, 2023, at the Opéra Comédie building.

  2. Sim&Cure, helping prevent brain aneurysm rupture

    With its Sim&Size, Sim&Treat, and Sim&Predict software solutions, the Montpellier startup wants to cover the entire patient journey by personalizing the therapeutic approach. The compan...

  3. The MedVallée roadmap respected to the letter

    Just ten months after its official launch, the MedVallée excellence hub in global health has already started working on 19 of its 30 assigned actions. Ten of those have already been completed. The ...

  4. Montpellier selected for University-Hospital Institute dedicated to autoimmune diseases

    As part of Plan France 2030, Montpellier has been chosen to host “Immun4Cure”, a University-Hospital Institute (IHU) dedicated to autoimmune diseases and innovative immunotherapies.

  5. Biomarker days: people as decision-makers regarding their own health

    The University of Montpellier’s Biohealth research cluster, AD'OCC Regional Agency, and Eurobiomed Competitiveness Cluster are organizing the 7th Biomarker Days.

  6. This year’s AFSSI Life Sciences event will be held in Montpellier

    In partnership with MedVallée, Eurobiomed, and AD’OCC, AFSSI is organizing the 10th edition of AFSSI Connections in Montpellier, a truly French annual marketplace for Life Science R&D.

  7. Medincell : historical succes in the heart of MedVallée

    MedinCell and its partner TEVA announced that US FDA approuved UZEDY™, a long-acting injectable medication for treating schizophrenia. MedinCell also raised 25 million euros.

  8. Medincell: historical success in the heart of MedVallée

    MedinCell and its partner TEVA announced that US FDA approuved UZEDY™, a long-acting injectable medication for treating schizophrenia. MedinCell also raised 25 million euros.

  9. MEDINCELL: HISTORICAL SUCCESS IN THE HEART OF MEDVALLÉE

    On April 28, the pharmaceutical company MedinCell and its partner TEVA announced that the US Food and Drug Administration (FDA) approved a long-acting injectable medication for treating schizophren...

  10. BtoHealth: the business and innovation event for the healthcare sector

    AD’OOC is organizing its first BtoB meeting for the health sector in the Occitanie region – “BtoHealth” – focusing on Life Sciences, in partnership with MedVallée.

Pages